captopril

Generic: captopril

Labeler: ajanta pharma usa inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name captopril
Generic Name captopril
Labeler ajanta pharma usa inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

captopril 50 mg/1

Manufacturer
Ajanta Pharma USA Inc.

Identifiers & Regulatory

Product NDC 27241-162
Product ID 27241-162_6425b4dc-ff42-4118-88dd-c369924fc080
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA212809
Listing Expiration 2026-12-31
Marketing Start 2019-12-13

Pharmacologic Class

Established (EPC)
angiotensin converting enzyme inhibitor [epc]
Mechanism of Action
angiotensin-converting enzyme inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 27241162
Hyphenated Format 27241-162

Supplemental Identifiers

RxCUI
308962 308963 308964 317173
UPC
0327241160011 0327241163012 0327241161018 0327241162015
UNII
9G64RSX1XD
NUI
N0000175562 N0000000181

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name captopril (source: ndc)
Generic Name captopril (source: ndc)
Application Number ANDA212809 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 50 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (27241-162-01)
  • 1000 TABLET in 1 BOTTLE (27241-162-10)
source: ndc

Packages (2)

Ingredients (1)

captopril (50 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "6425b4dc-ff42-4118-88dd-c369924fc080", "openfda": {"nui": ["N0000175562", "N0000000181"], "upc": ["0327241160011", "0327241163012", "0327241161018", "0327241162015"], "unii": ["9G64RSX1XD"], "rxcui": ["308962", "308963", "308964", "317173"], "spl_set_id": ["1fbc9b28-ff10-4b17-a359-e12b4330747e"], "pharm_class_epc": ["Angiotensin Converting Enzyme Inhibitor [EPC]"], "pharm_class_moa": ["Angiotensin-converting Enzyme Inhibitors [MoA]"], "manufacturer_name": ["Ajanta Pharma USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (27241-162-01)", "package_ndc": "27241-162-01", "marketing_start_date": "20191213"}, {"sample": false, "description": "1000 TABLET in 1 BOTTLE (27241-162-10)", "package_ndc": "27241-162-10", "marketing_start_date": "20191213"}], "brand_name": "Captopril", "product_id": "27241-162_6425b4dc-ff42-4118-88dd-c369924fc080", "dosage_form": "TABLET", "pharm_class": ["Angiotensin Converting Enzyme Inhibitor [EPC]", "Angiotensin-converting Enzyme Inhibitors [MoA]"], "product_ndc": "27241-162", "generic_name": "Captopril", "labeler_name": "Ajanta Pharma USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Captopril", "active_ingredients": [{"name": "CAPTOPRIL", "strength": "50 mg/1"}], "application_number": "ANDA212809", "marketing_category": "ANDA", "marketing_start_date": "20191213", "listing_expiration_date": "20261231"}